Comparison of Schistosoma mansoni irradiated cercariae and Sm23 DNA vaccines

Parasite Immunology

Volumn 27, Issue 9, 2005, Pages 341-349

  Ganley Leal, L M ^a,e   Guarner, J ^b   Todd, C W ^a   Da'Dara, A A ^c   Freeman Jr , G L ^a   Boyer, A E ^a   Harn, D A ^a   Secor, W Evan ^a,d  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA vaccine; Murine immunity; Schistosoma mansoni; Sm23

Indexed keywords

DNA VACCINE; GAMMA INTERFERON; MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CERCARIA; CONTROLLED STUDY; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCHISTOSOMA MANSONI; SPLEEN CELL;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERFERON TYPE II; LUNG; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; SCHISTOSOMA MANSONI; SKIN; SPLEEN; VACCINES, ATTENUATED; VACCINES, DNA;

ANIMALIA; MURINAE; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 25444490374     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00785.x     Document Type: Article

References (32)

1. Engels D, Chitsulo L, Montresor A & Savioli L. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica 2002; 82: 139-146.
2. Todd CW & Colley DG. Practical and ethical issues in the development of a vaccine against schistosomiasis mansoni. Am J Trop Med Hyg 2002; 66: 348-358.
3. Da'dara AA, Skelly PJ, Wang M & Harn DA. Immunization with plasmid DNA encoding the integral membrane protein, Sm23, elicits a protective immune response against schistosome infection in mice. Vaccine 2001; 20: 359-369.
4. Da'dara AA, Skelly PJ, Fatakdawala M, Visovatti S, Eriksson E & Harn DA. Comparative efficacy of the Schistosoma mansoni nucleic acid vaccine, Sm23, following microseeding or gene gun delivery. Parasite Immunol 2002; 24: 179-187.
5. McManus DP, Wong JYM, Zhou J et al. Recombinant paramyosin (rec-Sj-97) tested for immunogenicity and vaccine efficacy against Schistosoma japonicum in mice and water buffaloes. Vaccine 2001; 20: 870-878.
6. Zhang Y, Taylor MG, Johansen MV & Bickle QD. Vaccination of mice with a cocktail DNA vaccine induces a Th1-type immune response and partial protection against Schistosoma japonicum infection. Vaccine 2001; 20: 724-730.
7. Shalaby KA, Yin L, Thakur A, Christen L, Niles EG & LoVerde PT. Protection against Schistosoma mansoni utilizing DNA vaccination with genes encoding Cu/Zn cytosolic superoxide dismutase, signal peptide-containing superoxide dismutase and glutathione peroxidase enzymes. Vaccine 2003; 22: 130-136.
8. Berghist R, Al-Sherbiny M, Barakat R & Olds R. Blueprint for schistosomiasis vaccine development. Acta Tropica 2002; 82: 183-192.
9. Jankovic D, Wynn TA, Kullberg MC et al. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. J Immunol 1999; 162: 345-351.
10. Wynn TA & Hoffmann KF. Defining a schistosomiasis vaccination strategy - is it really Th1 versus Th2? Parasitol Today 2000; 16: 497-501.
11. Hoffmann KF, James SL, Cheever AW & Wynn TA. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 1999; 163: 927-938.
12. Crabtree JE & Wilson RA. Schistosoma mansoni: an ultrastructural examination of pulmonary migration. Parasitology 1986; 92: 343-354.
13. Coulson PS & Wilson RA. Examination of the mechanisms of pulmonary phase resistance to Schistosoma mansoni in vaccinated mice. Am J Trop Med Hyg 1988; 38: 529-539.
14. Smythies LE, Betts C, Coulson PS, Dowling M & Wilson RA. Kinetics and mechanism of effector focus formation in the lungs of mice vaccinated with irradiated cercariae of Schistosoma mansoni. Parasite Immunol 1996; 18: 359-369.
15. Wilson RA, Coulson PS, Betts C, Dowling MA & Smythies LE. Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine. Immunology 1996; 87: 275-282.
16. Mountford AP & Trottein F. Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol 2004; 20: 221-226.
17. Ward RE & McLaren D. Schistosoma mansoni: evidence that eosinophils and/or macrophages contribute to skin phase challenge attrition in vaccinated CBA/Ca mice. Parasitology 1988; 96: 63-84.
18. Mountford AP, Coulson PS, Pemberton RM, Smythies LE & Wilson RA. The generation of interferon-gamma-producing T lymphocytes in skin-draining lymph nodes, and their recruitment to the lungs, is associated with protective immunity to Schistosoma mansoni. Immunology 1992; 75: 250-256.
19. Riengrojpitak S, Anderson S & Wilson RA. Induction of immunity to Schistosoma mansoni: interaction of schistosomula with accessory leucocytes in murine skin and draining lymph nodes. Parasitology 1998; 117: 301-309.
20. Kumar P & Ramaswamy K. Vaccination with irradiated cercariae of Schistosoma mansoni preferentially induced the accumulation of interferon-gamma producing T cells in the skin and draining lymph nodes of mice. Parasitol Int 1999; 48: 109-119.
21. Hogg KG, Kumkate S, Anderson S & Mountford AP. Interleukin-12 p40 secretion by cutaneous CD11c+ and F4/80+ cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 2003; 71: 3563-3571.
22. Reynolds SR, Shoemaker CB & Harn DA. T and B cell epitope mapping of Sm23, an integral membrane protein of Schistosoma mansoni. J Immunol 1992; 149: 3995-4001.
23. Colley DG & Freeman GL Jr. Differences in adult Schistosoma mansoni worm burden requirements for the establishment of resistance to reinfection in inbred mice. I. CBA/J and C57BL/6 mice. Am J Trop Med Hyg 1980; 29: 1279-1285.
24. Smithers SR & Terry RJ. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology 1965; 55: 695-700.
25. Ramalho-Pinto FJ, Gazzinelli G, Howells RE, Mota-Santos TA, Figueiredo EA & Pellegrino J. Schistosoma mansoni: defined system for stepwise transformation of cercariae to schistosomule in vitro. Exp Parasitol 1974; 36: 360-372.
26. Colley DG, Todd CW, Lewis FA & Goodgame RW. Immune responses during human schistosomiasis mansoni. VI. In vitro nonspecific suppression of phytohemagglutinin responsiveness induced by exposure to certain schistosomal preparations. J Immunol 1979; 122: 1447-1453.
27. Tokunaga T, Yano O, Kuramoto E et al Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992; 36: 55-66.
28. Hardy RR & Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19: 595-621.
29. Freudenstein-Dan A, Gold D & Fishelson Z. Killing of schistosomes by elastase and hydrogen peroxide: implications for leukocyte-mediated schistosome killing. J Parasitol 2003; 89: 1129-1135.
30. Vignali DA, Crocker P, Bickle QD, Cobbold S, Waldmann H & Taylor MG. A role for CD4+ but not CD8+ T cells in immunity to Schistosoma mansoni induced by 20 krad-irradiated and Roll-3128-terminated infections. Immunology 1989; 67: 466-472.
31. Street M, Coulson PS, Sadler C et al. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine. J Immunol 1999; 163: 4489-4494.
32. Nascimento E, Leao IC, Pereira VR et al. Protective immunity of single and multi-antigen DNA vaccines against schistosomiasis. Mem Inst Oswaldo Cruz 2002; 97: 105-109.